Neuronetics Insider Macan Reports Change in Ownership

TL;DR

**Neuronetics insider Macan filed a Form 4, signaling a change in his stock holdings.**

AI Summary

This Form 4 filing indicates that William Andrew Macan, an insider at Neuronetics, Inc., reported a change in beneficial ownership of securities. The filing, dated March 24, 2026, for a period of report on March 19, 2026, is a standard disclosure required when an insider's holdings change. While the specific transaction details aren't in this summary, such filings are crucial for investors as they provide transparency into insider activity, which can signal confidence (or lack thereof) in the company's future prospects.

Why It Matters

Insider transactions can offer valuable insights into how those closest to the company view its future, potentially influencing investor sentiment and stock price.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of insider activity and does not inherently indicate a high risk, but rather provides transparency.

Analyst Insight

A smart investor would use this filing as a prompt to investigate the specific details of the transaction (buy or sell, quantity, price) within the full Form 4 document to understand William Andrew Macan's recent activity and its potential implications for Neuronetics, Inc.

Key Players & Entities

• MACAN WILLIAM ANDREW (person) — Reporting Person
• Neuronetics, Inc. (company) — Issuer of securities
• 0001758584 (person) — CIK of Reporting Person
• 0001227636 (company) — CIK of Issuer

FAQ

Key Financial Figures

• $1.48 — ctions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertak
• $1.20 — per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to pro

Filing Documents

• ownership.html (4)
• ownership.xml (4) — 4KB
• 0001193125-26-122290.txt ( ) — 5KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * MACAN WILLIAM ANDREW (Last) (First) (Middle) C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE (Street) MALVERN PENNSYLVANIA 19355 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Neuronetics, Inc. [ STIM ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, CLO and CS 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/19/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/19/2026 S 16,005 (1) D $ 1.34 (2) 897,270 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. 2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Patrick Devine, as Attorney-in-Fact 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR